Login to Your Account

Pharma: Other News To Note

Tuesday, April 16, 2013

Taro Pharmaceutical Industries Ltd., of Hawthorne, N.Y., said the FDA approved its new drug application for Topicort (desoximetasone) Topical Spray 0.25 percent, a corticosteroid indicated for the treatment of plaque psoriasis in patients 18 years of age or older.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription